迈阿密西班牙裔人群中安乃近的使用情况：在初级保健机构进行的一项调查结果报告
Metamizole use among Hispanics in Miami: report of a survey conducted in a primary care setting.
作者信息
Garcia Santiago, Canoniero Mariana, Lopes Gilberto, Soriano Andrés Omar
机构信息
Department of Medicine, University of Miami Leonard Miller School of Medicine, Miami, FL, USA.
出版信息
South Med J. 2006 Sep;99(9):924-6. doi: 10.1097/01.smj.0000233020.68212.8f.
BACKGROUND
Metamizole (dipyrone) is a myelotoxic, nonsteroidal anti-inflammatory agent that has been banned from the US market since 1979. However, dipyrone may be purchased in some areas of the US. We conducted a survey in a primary care setting in Miami, Florida to determine the prevalence of metamizole possession and use among Hispanics living in this area.
METHODS
Participants consisted of 137 Hispanic outpatients interviewed consecutively during a primary care visit in the month of February 2005.
RESULTS
Metamizole was possessed by 28% of the surveyed population. The most common reasons for using dipyrone were pain (72%) and fever (24%). The vast majority of patients had purchased the medication in Latin America (95%), in most instances without a prescription (95%). Nineteen patients (13%) had used the medication during the previous year.
CONCLUSIONS
Metamizole is available to Latino immigrants who reside in the US, despite the FDA ban imposed in 1977.
背景
安乃近是一种具有骨髓毒性的非甾体抗炎药，自1979年起已被禁止在美国市场销售。然而，在美国的一些地区仍可买到安乃近。我们在佛罗里达州迈阿密的一家初级保健机构进行了一项调查，以确定居住在该地区的西班牙裔人群中拥有和使用安乃近的情况。
方法
研究对象为2005年2月在一次初级保健就诊期间连续接受访谈的137名西班牙裔门诊患者。
结果
28%的受调查人群拥有安乃近。使用安乃近最常见的原因是疼痛（72%）和发热（24%）。绝大多数患者是在拉丁美洲购买的这种药物（95%），大多数情况下没有处方（95%）。19名患者（13%）在过去一年中使用过这种药物。
结论
尽管美国食品药品监督管理局在1977年实施了禁令，但居住在美国的拉丁裔移民仍可获得安乃近。
Zotero 插件